Results 181 to 190 of about 1,586,237 (267)

Evaluation of %CV and average glucose derived from pre- and postprandial 6-point glucose measurements for assessing hypoglycemia risk. [PDF]

J Diabetes Investig
Soga R, Torimoto K, Uemura F, Okada Y, Nakayamada S.   +4 more
europepmc   +1 more source

Comparative safety of sulfonylurea therapies on cardiovascular and severe hypoglycemia outcomes among adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation. [PDF]

BMJ Open Diabetes Res Care
Sklepinski S, Ratzki-Leewing AA, Herrin J, Swarna KS, Deng Y, Polley EC, Neumiller JJ, Galindo RJ, Umpierrez GE, Ross JS, Brito JP, Montori VM, Borah BJ, Maron BA, Mickelson MM, McCoy RG.   +15 more
europepmc   +1 more source

Effectiveness of empagliflozin in reducing hypoglycemic events as compared to sulfonylurea in type 2 diabetes patients during fasting in Ramadan: a single-center study. [PDF]

BMC Endocr Disord
Kiran Z, Fatima N, Baloch AA, Shaikh KUS, Hasan SM, Khan MU.   +5 more
europepmc   +1 more source

Insulin autoimmune hypoglycemia unmasking monoclonal gammopathy in type 2 diabetes. [PDF]

JCEM Case Rep
Prasad S, Sharma A, Parmar V, Jindal T, Kothia D, Bavaria D.   +5 more
europepmc   +1 more source

Sulfometuron-Methyl Disrupts Early Zebrafish Embryonic Development via Wnt/β-Catenin Signaling Pathway. [PDF]

Toxics
Zhang X, Liu J, Guo Y, Zhong J, Dong Y, Cheng S, Li Z, Qiang W, Wang H.   +8 more
europepmc   +1 more source

Glucagon-like Peptide-1 Receptor Agonists and Risk of Tuberculosis in Type 2 Diabetes. [PDF]

Nat Commun
Liao KM, Wu JY, Lai CC.
europepmc   +1 more source

Identifying high-risk combinations of metformin during COVID-19. [PDF]

PLoS One
Dimnjaković J, Buble T, Poljičanin T, Brborović H, Brađašević E, Brborović O.   +5 more
europepmc   +1 more source

The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. [PDF]

MedComm (2020)
Zou C, Jiang S, Li H, Zhao K, Cao D, Yang G.   +5 more
europepmc   +1 more source

The Development of Anti-Tumor Activity of Sulfonylurea Compounds

Hans Journal of Medicinal Chemistry, 2015
openaire   +1 more source

Glycemic Control and Utilization Risk With the Conversion of Glimepiride to Glipizide in Adults 64 Years and Older at an Integrated Health Care System. [PDF]

J Am Geriatr Soc
Lee EA, Lin JC, Kanter MH, Hsieh TI, Martin JP, Silverman JS, Yoshinaga MA, Chiu G, Asrat MF, Kohanim SY, Broder BI.   +10 more
europepmc   +1 more source